These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12880696)

  • 41. The properties of chitosan-gelatin membranes and scaffolds modified with hyaluronic acid by different methods.
    Mao JS; Liu HF; Yin YJ; Yao KD
    Biomaterials; 2003 Apr; 24(9):1621-9. PubMed ID: 12559822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ultrasonication of chitosan and chitosan nanoparticles.
    Tang ES; Huang M; Lim LY
    Int J Pharm; 2003 Oct; 265(1-2):103-14. PubMed ID: 14522123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan.
    Kawashima Y; Handa T; Kasai A; Takenaka H; Lin SY; Ando Y
    J Pharm Sci; 1985 Mar; 74(3):264-8. PubMed ID: 4009432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of preparation parameters on ultra low molecular weight chitosan/hyaluronic acid nanoparticles.
    Nazeri N; Avadi MR; Faramarzi MA; Safarian S; Tavoosidana G; Khoshayand MR; Amani A
    Int J Biol Macromol; 2013 Nov; 62():642-6. PubMed ID: 24099942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.
    Lu HD; Zhao HQ; Wang K; Lv LL
    Int J Pharm; 2011 Nov; 420(2):358-65. PubMed ID: 21911044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chitosan-poly(acrylic) acid polyionic complex: in vivo study to demonstrate prolonged gastric retention.
    Torrado S; Prada P; de la Torre PM; Torrado S
    Biomaterials; 2004 Feb; 25(5):917-23. PubMed ID: 14609680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. pH-sensitive polyelectrolyte complex gel microspheres composed of chitosan/sodium tripolyphosphate/dextran sulfate: swelling kinetics and drug delivery properties.
    Lin WC; Yu DG; Yang MC
    Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):143-51. PubMed ID: 16054345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications.
    Dini E; Alexandridou S; Kiparissides C
    J Microencapsul; 2003; 20(3):375-85. PubMed ID: 12881117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biodegradable hyaluronic acid/n-carboxyethyl chitosan/protein ternary complexes as implantable carriers for controlled protein release.
    Jiang H; Wang Y; Huang Q; Li Y; Xu C; Zhu K; Chen W
    Macromol Biosci; 2005 Dec; 5(12):1226-33. PubMed ID: 16307434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and partial characterization of hydrogels obtained via glutaraldehyde crosslinking of acetylated chitosan and of hyaluronan derivatives.
    Crescenzi V; Francescangeli A; Taglienti A; Capitani D; Mannina L
    Biomacromolecules; 2003; 4(4):1045-54. PubMed ID: 12857091
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles.
    Contreras-Ruiz L; de la Fuente M; García-Vázquez C; Sáez V; Seijo B; Alonso MJ; Calonge M; Diebold Y
    Cornea; 2010 May; 29(5):550-8. PubMed ID: 20335805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chitosan membrane: tool for chromium (III) recovery from aqueous solutions.
    Pietrelli L; Xingrong L
    Ann Chim; 2004; 94(5-6):389-98. PubMed ID: 15279098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
    Pan Y; Li YJ; Zhao HY; Zheng JM; Xu H; Wei G; Hao JS; Cui FD
    Int J Pharm; 2002 Dec; 249(1-2):139-47. PubMed ID: 12433442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyaluronic acid grafted with poly(ethylene glycol) as a novel peptide formulation.
    Moriyama K; Ooya T; Yui N
    J Control Release; 1999 May; 59(1):77-86. PubMed ID: 10210724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines.
    Calvo P; Remuñan-López C; Vila-Jato JL; Alonso MJ
    Pharm Res; 1997 Oct; 14(10):1431-6. PubMed ID: 9358557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Usage of chitosan as a pharmaceutical material effectiveness as an additional additives of sodium alginate].
    Miyazaki T; Komuro T; Yomota C; Okada S
    Eisei Shikenjo Hokoku; 1990; (108):95-7. PubMed ID: 1364368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chitosan salts as nasal sustained delivery systems for peptidic drugs.
    Cerchiara T; Luppi B; Bigucci F; Zecchi V
    J Pharm Pharmacol; 2003 Dec; 55(12):1623-7. PubMed ID: 14738587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sulfadiazine modified CS/HA PEC destined to wound dressing.
    Profire L; Pieptu D; Dumitriu RP; Dragostin O; Vasile C
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):525-31. PubMed ID: 24340541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of chitosan and hydroxypropylchitosan in drug formulations to effect sustained release.
    Machida Y; Nagai T; Abe M; Sannan T
    Drug Des Deliv; 1986 Nov; 1(2):119-30. PubMed ID: 3509325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of chitosan on progesterone release from hydroxypropyl-beta-cyclodextrin complexes.
    Cerchiara T; Luppi B; Bigucci F; Zecchi V
    Int J Pharm; 2003 Jun; 258(1-2):209-15. PubMed ID: 12753767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.